Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Proposal for the breakdown of increased cancer healthcare cost and its improvement.

Koinuma N.

Jpn J Clin Oncol. 2013 Apr;43(4):351-6. doi: 10.1093/jjco/hyt015. Epub 2013 Feb 18. Review.

PMID:
23423810
2.

[Problems with countermeasures for health insurance treatment in neurology].

Ito M.

Rinsho Shinkeigaku. 2013;53(11):923-5. Japanese.

PMID:
24291834
3.

American Society of Clinical Oncology guidance statement: the cost of cancer care.

Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA, Schnipper LE; American Society of Clinical Oncology.

J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6.

PMID:
19581533
4.

The financial burden of cancer care: do patients in the US know what to expect?

Peppercorn J.

Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):835-42. doi: 10.1586/14737167.2014.963558. Epub 2014 Oct 1. Review.

PMID:
25269513
5.

Cost of cancer care: issues and implications.

Meropol NJ, Schulman KA.

J Clin Oncol. 2007 Jan 10;25(2):180-6. Review.

PMID:
17210937
6.

Modeling healthcare expenditures: overview of the literature and evidence from a panel time-series model.

van Elk R, Mot E, Franses PH.

Expert Rev Pharmacoecon Outcomes Res. 2010 Feb;10(1):25-35. doi: 10.1586/erp.09.72. Review.

PMID:
20121562
7.

Finance for health care: part of a broad canvas.

Evlo K, Carrin G.

World Health Forum. 1992;13(2-3):165-70.

PMID:
1418329
8.

Cost of cancer care: the patient perspective.

Kim P.

J Clin Oncol. 2007 Jan 10;25(2):228-32. Review.

PMID:
17210945
9.

Beware the Medical-Industrial Complex.

Stevens CW, Glatstein E.

Oncologist. 1996;1(4):IV-V.

PMID:
10388005
10.

Is high and growing spending on cancer treatment and prevention harmful to the United States economy?

Pauly MV.

J Clin Oncol. 2007 Jan 10;25(2):171-4. No abstract available.

PMID:
17210935
11.

The economics of cancer care in the United States.

Farina KL.

Am J Manag Care. 2012 Feb;18(1 Spec No.):SP38-9. Review. No abstract available.

12.
13.

The hidden costs of cancer care: an overview with implications and referral resources for oncology nurses.

Wagner L, Lacey MD.

Clin J Oncol Nurs. 2004 Jun;8(3):279-87. Review.

PMID:
15208822
14.
15.

[Prospects for national health expenditure in Japan].

Sakoi M.

Gan To Kagaku Ryoho. 2000 Aug;27(9):1337-46. Japanese.

PMID:
10969587
16.

Economic burden of cancer in the United States: estimates, projections, and future research.

Yabroff KR, Lund J, Kepka D, Mariotto A.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2006-14. doi: 10.1158/1055-9965.EPI-11-0650.

17.

Financial Toxicity of Cancer Care: It's Time to Intervene.

Zafar SY.

J Natl Cancer Inst. 2015 Dec 11;108(5). pii: djv370. doi: 10.1093/jnci/djv370. Print 2016 May.

PMID:
26657334
18.

Does public insurance provide better financial protection against rising health care costs for families of children with special health care needs?

Yu H, Dick AW, Szilagyi PG.

Med Care. 2008 Oct;46(10):1064-70. doi: 10.1097/MLR.0b013e318185cdf2.

PMID:
18815528
19.

Cancer insurance policies in Japan and the United States.

Bennett CL, Weinberg PD, Lieberman JJ.

West J Med. 1998 Jan;168(1):17-22. Review.

20.

[Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].

Stäbler W, Wagner B.

Klin Padiatr. 2003 May-Jun;215(3):179-84. German.

PMID:
12778360

Supplemental Content

Support Center